Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Frailty Aging ; 7(3): 187-192, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30095150

RESUMO

OBJECTIVE: Develop and evaluate the feasibility and validity of the Nutrition and Functionality Assessment (NFA) which identifies "target" older adults who could benefit from a personalized program following evaluation of their nutrition status and physical functionality. DESIGN: Cross-sectional study. SETTING: Community and geriatric day-care centers and university in Japan. PARTICIPANTS: 267 older adults aged 65-90. MEASUREMENTS: The "target" individuals were screened based on gait speed (0.6-1.5 m/s). Nutrition (Mini Nutrition Assessment-short form and protein intake), strength (30s chair sit-to-stand and hand-grip strength) and endurance (6-minute walk) were assessed. Physical activity was monitored using a tri-axil accelerometer for a week. Fried frailty phenotype was also assessed. RESULTS: Out of 267 individuals, 185 (69%) had gait speed between 0.6-1.5 m/s, corresponding to our "target" group from which, 184 (95%) completed the nutrition and physical functionality assessments with the physical activity monitoring. The NFA was completed in approximately 30 minutes. No adverse events directly due to the NFA were reported. NFA physical functionality and global scores were significantly related to frailty phenotype but nutrition score was not related to frailty phenotype. CONCLUSION: The study demonstrated that the NFA is a safe and feasible tool to screen target older adults and simultaneously evaluate their nutritional status and physical functionality. Validity of the NFA was partially confirmed by the significant association of the global and physical functionality scores with frailty phenotype. More studies are required to validate and maximize the applicability of the NFA in communities and institutions in Japan and elsewhere.


Assuntos
Avaliação Geriátrica , Avaliação Nutricional , Desempenho Físico Funcional , Idoso , Idoso de 80 Anos ou mais , Estudos Transversais , Humanos , Japão
2.
Amino Acids ; 45(5): 1123-31, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23913268

RESUMO

Low calorie diets are designed to reduce body weight and fat mass, but they also lead to a detrimental loss of lean body mass, which is an important problem for overweight people trying to lose weight. In this context, a specific dietary intervention that preserves muscle mass in people following a slimming regime would be of great benefit. Leucine (LEU) and Citrulline (CIT) are known to stimulate muscle protein synthesis (MPS) in post-prandial and post-absorptive state, respectively. This makes them interesting bioactive components to test in the context of dietary restriction. We tested the concept of combining LEU and CIT in adult female rats. We postulated that the sequential administration of LEU (mixed in chow) and CIT (given in drinking water before a rest period) could be beneficial for preservation of muscle function during food restriction. Sixty female rats (22 weeks old) were randomized into six groups: one group fed ad libitum with a standard diet (C) and five food-restricted groups (60 % of spontaneous intake for 2 weeks) receiving a standard diet (R group), a CIT-supplemented diet (0.2 or 1 g/kg/day, CIT0.2 group and CIT1 group, respectively), a LEU-supplemented diet (1.0 g/kg/day) or a CIT + LEU-supplemented diet (CIT + LEU 1.0 g/kg/day each). At the end of the experiment, body composition, muscle contractile properties and muscle protein synthesis (MPS) rate were studied in the tibialis anterior muscle. Dietary restriction tended to decrease MPS (R: 2.5 ± 0.2 vs. C: 3.4 ± 0.4 %/day, p = 0.06) and decrease muscle strength (R: 3,045 ± 663 vs. C: 5,650 ± 661 A.U., p = 0.03). Only CIT administration (1 g/kg) was able to restore MPS (CIT1: 3.4 ± 0.3 vs. R: 2.5 ± 0.2 %/day, p = 0.05) and increase muscle maximum tetanic force (CIT1: 441 ± 15 vs. R: 392 ± 22 g, p = 0.05) and muscle strength (CIT1: 4,259 ± 478 vs. R: 3,045 ± 663 A.U., p = 0.05). LEU had no effect and CIT + LEU supplementation had few effects, limited to adipose mass and fatigue force. The results of this study highlight the ability of CIT alone to preserve muscle function during dietary restriction. Surprisingly, LEU antagonized some effects of CIT. The mechanisms involved in this antagonistic effect warrant further study.


Assuntos
Restrição Calórica , Citrulina/metabolismo , Músculo Esquelético/fisiologia , Animais , Composição Corporal , Peso Corporal , Feminino , Humanos , Contração Muscular , Ratos , Ratos Sprague-Dawley
3.
Clin Exp Immunol ; 162(2): 298-305, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20731673

RESUMO

One of the main secondary toxic side effects of anti-mitotic agents used to treat cancer patients is intestinal mucositis. Previous data showed that cathepsin D activity, contributing to the proteolytic lysosomal pathway, is up-regulated during intestinal mucositis in rats. At the same time, cathepsin inhibition limits intestinal damage in animal models of inflammatory bowel diseases. The aim of this study was to evaluate the effects of cathepsin inhibition on methotrexate-induced mucositis in rats. Male Sprague-Dawley rats received saline solution subcutaneously as the control group or 2·5 mg/kg of methotrexate for 3 days (D0-D2). From D0 to D3 methotrexate-treated rats also received intraperitoneal injections of pepstatin A, a specific inhibitor of cathepsin D or E64, an inhibitor of cathepsins B, H and L, or vehicle. Rats were euthanized at D4 and jejunal samples were collected. Body weight and food intake were partially preserved in rats receiving E64 compared with rats receiving vehicle or pepstatin A. Cathepsin D activity, used as a marker of lysosomal pathway, was reduced both in E64 and pepstatin-treated rats. However, villus atrophy and intestinal damage observed in methotrexate-treated rats were restored in rats receiving E64 but not in rats receiving pepstatin A. The intramucosal concentration of proinflammatory cytokines, interleukin-1ß and cytokine-induced neutrophil chemoattractant (CINC)-2, was markedly increased in methotrexate-treated rats receiving vehicle or pepstatin A but not after E64 treatment. In conclusion, a large broad inhibition of cathepsins could represent a new potential target to limit the severity of chemotherapy-induced mucositis as opposed to the inhibition of cathepsin D alone.


Assuntos
Catepsinas/antagonistas & inibidores , Mucosa Intestinal/efeitos dos fármacos , Metotrexato/farmacologia , Mucosite/induzido quimicamente , Mucosite/prevenção & controle , Animais , Peso Corporal/efeitos dos fármacos , Catepsina D/antagonistas & inibidores , Catepsina D/metabolismo , Catepsinas/metabolismo , Quimiocinas CXC/genética , Quimiocinas CXC/metabolismo , Ingestão de Alimentos/efeitos dos fármacos , Expressão Gênica/efeitos dos fármacos , Expressão Gênica/genética , Inflamação/metabolismo , Inflamação/prevenção & controle , Interleucina-1beta/genética , Interleucina-1beta/metabolismo , Mucosa Intestinal/metabolismo , Mucosa Intestinal/patologia , Leucina/análogos & derivados , Leucina/farmacologia , Leucina/uso terapêutico , Masculino , Mucosite/metabolismo , Mucosite/patologia , Pepstatinas/farmacologia , Pepstatinas/uso terapêutico , Peptídeo Hidrolases/metabolismo , Complexo de Endopeptidases do Proteassoma/metabolismo , Ratos , Ratos Sprague-Dawley , Fator de Necrose Tumoral alfa/genética , Fator de Necrose Tumoral alfa/metabolismo
4.
Artigo em Inglês | MEDLINE | ID: mdl-18799858

RESUMO

Osteopaenia is a common complication of inflammatory bowel diseases (IBD). However, the mechanisms of bone loss are still the subject of debate. The aims of this study were to investigate bone loss in HLA-B27 transgenic rats, a spontaneous model of colitis and to compare the results provided by the usual markers of bone remodelling and by direct measurement of bone protein synthesis. Systemic inflammation was evaluated in HLA-B27 rats and control rats from 18 to 27 months of age. Then bone mineral density, femoral failure load, biochemical markers of bone remodelling and protein synthesis in tibial epiphysis were measured. Bone mineral density was lower in HLA-B27 rats than in controls. Plasma osteocalcin, a marker of bone formation, and fractional protein synthesis rate in tibial epiphysis did not differ between the two groups of rats. In contrast, urinary excretion of deoxypyridinoline, a marker of bone resorption, was significantly increased in HLA-B27 rats. The present results indicate that bone fragility occurs in HLA-B27 rats and mainly results from an increase in bone resorption. Systemic inflammation may be the major cause of the disruption in bone remodelling homeostasis observed in this experimental model of human IBD.


Assuntos
Doenças Ósseas Metabólicas/etiologia , Remodelação Óssea , Antígeno HLA-B27/metabolismo , Aminoácidos/urina , Animais , Biomarcadores/sangue , Biomarcadores/urina , Densidade Óssea , Doenças Ósseas Metabólicas/sangue , Doenças Ósseas Metabólicas/fisiopatologia , Doenças Ósseas Metabólicas/urina , Reabsorção Óssea/complicações , Reabsorção Óssea/urina , Colite/complicações , Colite/genética , Modelos Animais de Doenças , Epífises/metabolismo , Fêmur/fisiopatologia , Antígeno HLA-B27/genética , Masculino , Osteocalcina/sangue , Osteogênese , Biossíntese de Proteínas , Ratos , Ratos Endogâmicos F344 , Ratos Transgênicos , Resistência à Tração , Tíbia/metabolismo
5.
Artigo em Inglês | MEDLINE | ID: mdl-19147979

RESUMO

Age-associated low-grade systemic inflammation may contribute to sarcopenia. We hypothesized that skeletal muscle mass and protein synthesis rate would be reduced in old rats exhibiting persistent low-grade inflammation compared to age-matched controls. Male 24-month-old Wistar rats exhibiting a low-grade systemic inflammation for at least one month (LGI group) were compared to non-inflamed rats (C group). Tissue protein synthesis rates were quantified using the L-[1-(13)C]-valine flooding dose method. Body weight, gastrocnemius muscle and spleen weights were not significantly different between groups, but liver and small intestine weights were 13 and 14% higher in LGI than in C. Fractional and absolute protein synthesis rates were not significantly different between groups for gastrocnemius, spleen and small intestine, but higher for liver in LGI than in C. Despite an increase in liver protein synthesis, low-grade inflammation did not reduce skeletal muscle mass, suggesting that age-associated low-grade systemic inflammation occurs independently of sarcopenia.


Assuntos
Envelhecimento/patologia , Proteínas Musculares/biossíntese , Músculo Esquelético/metabolismo , Músculo Esquelético/patologia , Atrofia Muscular/metabolismo , Atrofia Muscular/patologia , Envelhecimento/fisiologia , Animais , Inflamação/metabolismo , Inflamação/patologia , Inflamação/fisiopatologia , Masculino , Proteínas Musculares/fisiologia , Atrofia Muscular/complicações , Ratos , Ratos Wistar
6.
Dig Dis Sci ; 49(2): 339-46, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15104381

RESUMO

HLA-B27 transgenic rats spontaneously developing a chronic inflammation mainly involving the colon are recognized as a powerful animal model for IBD. We investigated the mucin production in 6-month-old HLA-B27 rats by measuring in vivo fractional synthesis rate (FSR) and expression of mucins. In the inflamed colon of HLA-B27 rats, the mucin FSR was stimulated by 75% compared to F-344 controls, while MUC2,3 mRNA expression was unchanged. A local depletion in mucus-containing goblet cells was observed, suggesting a rapid mucin production/release and/or a real global decrease in goblet cell number. In the noninflamed jejunum of HLA-B27 rats, the mucin FSR was reduced by 35% compared to controls, while MUC2,3 mRNA expression was unchanged. Different alterations in mucin metabolism and expression are observed between HLA-B27 rats and a model of chemically induced chronic colitis (DSS-treated rats), suggesting that mucin alterations may be dependent on the animal model and colitis underlying mechanism.


Assuntos
Colite/imunologia , Antígeno HLA-B27/genética , Antígeno HLA-B27/imunologia , Mucinas/biossíntese , Aminoácidos/análise , Animais , Animais Geneticamente Modificados , Doença Crônica , Colite/patologia , Colo/patologia , Mucosa Intestinal/patologia , Jejuno/metabolismo , Masculino , Mucina-2 , Mucina-3 , Mucinas/química , Mucinas/genética , RNA Mensageiro/metabolismo , Ratos , Ratos Endogâmicos F344
7.
Dig Dis Sci ; 48(7): 1366-73, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12870797

RESUMO

We evaluated the small and large intestinal mucin production in a rat model of human ulcerative colitis by measuring the in vivo fractional synthesis rate (FSR) and the expression of mucins. A chronic colitis was induced by oral administration of 5% dextran sulfate sodium (DSS) for 9 days followed by 2% DSS for 18 days. DSS-treated rats showed increased colonic MUC2,3 mRNA levels compared pair-fed controls. The mucin FSR was unaffected while mucin-containing goblet cells were depleted in the vicinity of lesions. In the small intestine, no inflammatory lesions were observed but ileal MUC2 mRNA levels and mucin FSR were decreased by 46% and 21%, respectively. Finally, DSS-treated rats showed a marked decrease in mucin's threonine + serine content all along the gut, which may lead to a reduction of potential O-glycosylation sites. Our data indicate that the chronic colitis may impair the mucus layer protective function all along the gut.


Assuntos
Enterocolite/metabolismo , Mucinas/biossíntese , Mucinas/química , Animais , Sulfato de Dextrana , Enterocolite/induzido quimicamente , Células Caliciformes/efeitos dos fármacos , Células Caliciformes/fisiologia , Intestinos/química , Intestinos/efeitos dos fármacos , Masculino , Modelos Animais , Ratos , Ratos Sprague-Dawley , Serina/análise , Treonina/análise
8.
Am J Physiol Endocrinol Metab ; 279(6): E1391-7, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11093928

RESUMO

Methionine transsulfuration in plasma and liver, and plasma methionine and cysteine kinetics were investigated in vivo during the acute phase of sepsis in rats. Rats were infected with an intravenous injection of live Escherichia coli, and control pair-fed rats were injected with saline. Two days after injection, the rats were infused for 6 h with [(35)S]methionine and [(15)N]cysteine. Transsulfuration was measured from the transfer rate of (35)S from methionine to cysteine. Liver cystathionase activity was also measured. Infection significantly increased (P < 0.05) the contribution of transsulfuration to cysteine flux in both plasma and liver (by 80%) and the contribution of transsulfuration to plasma methionine flux (by 133%). Transsulfuration measured in plasma was significantly (P < 0.05) higher in infected rats than in pair-fed rats (0.68 and 0.25 micromol. h(-1). 100 g(-1), respectively). However, liver cystathionase specific activity was decreased by 17% by infection (P < 0.05). Infection increased methionine flux (16%, P < 0.05) less than cysteine flux (38%, P < 0.05). Therefore, the plasma cysteine flux was higher than that predicted from estimates of protein turnover based on methionine data, probably because of enhanced glutathione turnover. Taken together, these results suggest an increased cysteine requirement in infection.


Assuntos
Metionina/farmacocinética , Sepse/metabolismo , Enxofre/farmacocinética , Animais , Anorexia/metabolismo , Cistationina gama-Liase/sangue , Cisteína/sangue , Cisteína/farmacocinética , Ingestão de Alimentos , Infecções por Escherichia coli/metabolismo , Infecções por Escherichia coli/patologia , Fígado/metabolismo , Fígado/patologia , Masculino , Metionina/sangue , Isótopos de Nitrogênio , Tamanho do Órgão , Ratos , Ratos Sprague-Dawley , Sepse/patologia , Radioisótopos de Enxofre
9.
Am J Physiol Endocrinol Metab ; 279(2): E244-51, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10913022

RESUMO

Plasma albumin is well known to decrease in response to inflammation. The rate of albumin synthesis from both liver and plasma was measured in vivo by use of a large dose of L-[(2)H(3)-(14)C]valine in rats injected intravenously with live Escherichia coli and in pair-fed control rats during the acute-phase period (2 days postinfection). The plasma albumin concentration was reduced by 50% in infected rats compared with pair-fed animals. Infection induced a fall in both liver albumin mRNA levels and albumin synthesis relative to total liver protein synthesis. However, absolute liver albumin synthesis rate (ASR) was not affected by infection. In plasma, albumin fractional synthesis rate was increased by 50% in infected animals compared with pair-fed animals. The albumin ASR estimated in the plasma was similar in the two groups. These results suggest that hypoalbuminemia is not due to reduced albumin synthesis during sepsis. Moreover, liver and plasma albumin ASR were similar. Therefore, albumin synthesis measured in the plasma is a good indicator of liver albumin synthesis.


Assuntos
Infecções por Escherichia coli/metabolismo , Fígado/metabolismo , RNA Mensageiro/metabolismo , Sepse/metabolismo , Albumina Sérica/biossíntese , Proteínas de Fase Aguda/metabolismo , Reação de Fase Aguda/sangue , Reação de Fase Aguda/metabolismo , Animais , Peso Corporal , Radioisótopos de Carbono , Deutério , Infecções por Escherichia coli/sangue , Fibrinogênio/metabolismo , Alimentos Formulados , Fígado/química , Masculino , Tamanho do Órgão , Orosomucoide/metabolismo , Proteínas/análise , Ratos , Sepse/sangue , Albumina Sérica/genética , Valina/metabolismo , Valina/farmacocinética , alfa-Macroglobulinas/metabolismo
10.
J Nutr ; 130(5): 1239-46, 2000 May.
Artigo em Inglês | MEDLINE | ID: mdl-10801925

RESUMO

Glutathione metabolism during infection has been poorly documented. Glutathione concentrations and synthesis rates were studied in infected rats (2 d after infection) and in pair-fed controls. Glutathione synthesis rates were determined in liver, spleen, lung, small and large intestine, skeletal muscle, heart and blood by a 4-h or 6-h (15)N cysteine infusion. The activities of four hepatic enzymes involved in glutathione metabolism were also determined. Glutathione synthesis rates were significantly greater in liver (+465%), spleen (+388%), large intestine (+109%), lung (+100%), muscle (+91%) and heart (+80%) of infected rats compared with pair-fed controls. Glutathione concentrations were also greater in these tissues but were unaffected in small intestine and lower in blood. In keeping with the stimulation of liver glutathione synthesis, the activities of liver gamma-glutamyl-cysteine synthetase and glutathione reductase were significantly greater in liver of infected rats than of pair-fed rats. From the present study, we estimate that glutathione synthesis accounts for at least 40% of the enhanced cysteine utilization during infection. This increased utilization may be the primary cause of an enhanced cysteine requirement in infection.


Assuntos
Cisteína/metabolismo , Glutationa/metabolismo , Fígado/metabolismo , Sepse/metabolismo , Animais , Peso Corporal , Cisteína/administração & dosagem , Cisteína/sangue , Glutamato-Cisteína Ligase/metabolismo , Glutationa/biossíntese , Glutationa Redutase/metabolismo , Infusões Intravenosas , Mucosa Intestinal/metabolismo , Fígado/enzimologia , Masculino , Tamanho do Órgão , Ratos , Ratos Sprague-Dawley , Baço/metabolismo
12.
J Chromatogr B Biomed Sci Appl ; 732(1): 127-35, 1999 Sep 10.
Artigo em Inglês | MEDLINE | ID: mdl-10517229

RESUMO

A gas chromatographic-mass spectrometric (GC-MS) procedure for the determination of stable isotope labelled glutathione has been applied to animal and human samples. The method, based on preparation of the N,S-ethoxycarbonyl methyl ester derivative of the intact peptide, is rapid and requires little or minor tissue treatment. The same method was applied to cysteine. The method was found to be reliable in terms of within-day and between-day precision, accuracy and linearity. The procedure was applied in humans and animals to determine in vivo the glutathione fractional synthesis rate using labelled cysteine infusion. The glutathione fractional synthesis rate was found to be 22.5%/day in blood from a healthy volunteer and 337+/-29%/day in rat liver.


Assuntos
Cisteína/análise , Cromatografia Gasosa-Espectrometria de Massas/métodos , Glutationa/análise , Animais , Cisteína/sangue , Cisteína/química , Glutationa/sangue , Glutationa/química , Humanos , Isótopos/análise , Suínos
13.
J Endocrinol ; 163(1): 15-24, 1999 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-10495402

RESUMO

We investigated the ability of pentoxifylline (PTX) to modulate protein synthesis and degradation in the presence and absence of insulin during incubation of epitrochlearis muscle, 2 or 6 days after injection of Escherichia coli. On days 2 and 6 after infection, protein synthesis was inhibited by 25%, whereas proteolysis was enhanced by 75%. Insulin (2 nM) in vitro stimulated protein synthesis in muscles from infected rats to the same extent as in controls. The ability of insulin to limit protein degradation was severely blunted 48 h after infection. On day 6 after infection, insulin inhibited proteolysis to a greater extent than on day 2. PTX suppressed the increase in plasma concentrations of tumor necrosis factor more than 600-fold after injection of bacteria, and partially prevented the inhibition of protein synthesis and stimulation of protein degradation during sepsis. Moreover, PTX administration maintained the responsiveness of protein degradation to insulin during sepsis. Thus cytokines may influence skeletal muscle protein metabolism during sepsis, both indirectly through inhibition of the effects of insulin on proteolysis, and directly on the protein synthesis and degradation machinery.


Assuntos
Infecções por Escherichia coli/metabolismo , Insulina/uso terapêutico , Proteínas Musculares/metabolismo , Músculo Esquelético/metabolismo , Pentoxifilina/uso terapêutico , Inibidores de Fosfodiesterase/uso terapêutico , Análise de Variância , Animais , Técnicas de Cultura , Infecções por Escherichia coli/tratamento farmacológico , Membro Anterior , Masculino , Proteínas Musculares/biossíntese , Fenilalanina/metabolismo , Ratos , Ratos Sprague-Dawley , Fator de Necrose Tumoral alfa/metabolismo , Tirosina/metabolismo
14.
Infect Immun ; 67(3): 1079-85, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10024546

RESUMO

Most animal models of sepsis induced high mortality or early recovery and do not mimic the long-lasting catabolic state observed in patients. The purpose of this study is to develop a model of sepsis which reproduces these disorders, especially the long-lasting muscle wasting. This report summarizes our observations in a series of seven experiments using this model with rats to study the route of live Escherichia coli administration, dose of bacteria, reproducibility of the model, bacterial count in tissues, comparison of injection of live or dead bacteria, metabolic perturbations linked to infection, and potential role of tumor necrosis factor alpha (TNF-alpha) in muscle wasting. After intravenous infection, animals were anorexic and the catabolic state was long-lasting: body weight loss for 2 to 3 days followed by a chronic wasting state for several days. Liver, spleen, lung protein content, and plasma concentration of alpha2-macroglobulin were increased 2 and 6 days after infection. At 6 days, muscle protein content was substantially (-40%) reduced. The plasma TNF-alpha level measured 1.5 h after infection correlated with body weight loss observed 9 days later. The inhibition of TNF-alpha secretion by administration of pentoxifylline 1 h before infection reduced muscle wasting and activation of proteolysis at day 2 and abolished them at day 6. This septic model mimics in rats the prolonged protein metabolism alterations and muscle atrophy characteristics of infected patients and thus is useful for studying the impact of nutritional support on outcome.


Assuntos
Sepse/metabolismo , Animais , Peso Corporal , Contagem de Colônia Microbiana , Modelos Animais de Doenças , Masculino , Ratos , Ratos Sprague-Dawley , Fator de Necrose Tumoral alfa/análise , Síndrome de Emaciação/metabolismo
15.
Am J Physiol ; 275(5): R1412-9, 1998 11.
Artigo em Inglês | MEDLINE | ID: mdl-9791055

RESUMO

To explore the regulation of the acute phase response in vivo, the effects of pentoxifylline (PX) treatment (100 mg/kg ip 1 h before infection) were investigated in infected and pair-fed rats 2 and 6 days after an intravenous injection of live bacteria (Escherichia coli). PX treatment prevented the increase in plasma tumor necrosis factor (TNF)-alpha (peak 1.5 h after the infection) and resulted in an 84 and 61% inhibition of plasma interleukin (IL)-1beta and IL-6, respectively (peaks at 3 h). Plasma corticosterone kinetics were not modified by the treatment. Infection increased alpha1-acid glycoprotein (AGP), alpha2-macroglobulin (A2M), and fibrinogen plasma concentrations and decreased albumin levels. PX significantly reduced AGP plasma concentration as early as day 2 in infected animals but reduced A2M and fibrinogen plasma levels only at day 6. The treatment had no effect on the albumin plasma concentration. Hepatic AGP and fibrinogen mRNA levels increased in infected rats, whereas those of A2M were unchanged and those of albumin were decreased. Two days after infection, AGP and fibrinogen mRNA levels were reduced in treated infected animals. PX was ineffective in modifying those of A2M and albumin. These data demonstrate, in vivo, that different acute phase proteins are individually regulated in sepsis. The in vivo effects of PX treatment support the hypothesis that TNF-alpha plays an important role in the regulation of AGP production, whereas other factors seem to be involved in the regulation of A2M, fibrinogen, and albumin expression.


Assuntos
Proteínas de Fase Aguda/metabolismo , Infecções por Escherichia coli/prevenção & controle , Sequestradores de Radicais Livres/farmacologia , Interleucina-1/metabolismo , Interleucina-6/metabolismo , Pentoxifilina/farmacologia , Sepse/prevenção & controle , Fator de Necrose Tumoral alfa/metabolismo , Proteínas de Fase Aguda/imunologia , Animais , Infecções por Escherichia coli/sangue , Infecções por Escherichia coli/imunologia , Masculino , Ratos , Ratos Sprague-Dawley , Sepse/sangue , Sepse/imunologia
16.
Am J Physiol ; 275(4): E584-93, 1998 10.
Artigo em Inglês | MEDLINE | ID: mdl-9755076

RESUMO

Skeletal muscle catabolism is a characteristic metabolic response to sepsis. We investigated the ability of physiological insulin (2 nM) or insulin-like growth factor I (IGF-I, 10 nM) concentrations to modify protein metabolism during incubation of epitrochlearis 2, 6, or 15 days after injection of live Escherichia coli. On days 2 and 6 postinfection, skeletal muscle exhibited an exacerbated negative protein balance resulting from both an inhibition in protein synthesis (25%) and an enhanced proteolysis (90%) compared with controls. By day 15 postinfection, protein balance in infected rats was significantly improved compared with either day 2 or 6. At this time, protein synthesis was augmented and protein degradation was decreased in infected rats relative to day 6. Insulin or IGF-I stimulated protein synthesis in muscles from septic and control rats in vitro to the same extent at each time point examined. The ability of insulin or IGF-I to limit protein degradation was severely blunted 48 h after infection. On day 6 postinfection, the effect of insulin or IGF-I to inhibit proteolysis was more pronounced than on day 2. Incubation with IGF-I limited proteolysis to a greater extent than insulin on both days in infected but not control rats. By day 15, insulin diminished proteolysis to the same extent as in controls. The results suggest that injection of bacteria causes fundamental derangements in protein metabolism that persist for days after infection.


Assuntos
Bacteriemia/metabolismo , Infecções por Escherichia coli/metabolismo , Fator de Crescimento Insulin-Like I/farmacologia , Insulina/farmacologia , Proteínas Musculares/metabolismo , Músculo Esquelético/metabolismo , Animais , Relação Dose-Resposta a Droga , Cinética , Masculino , Proteínas Musculares/biossíntese , Músculo Esquelético/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Valores de Referência
17.
Clin Sci (Lond) ; 94(4): 413-23, 1998 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9640347

RESUMO

1. Sepsis was induced in rats by an intravenous injection of live bacteria. Infected and pair-fed animals were studied before the infection, in an acute septic phase (day 2 post-infection), in a chronic septic phase (day 6) and in a late septic phase (day 10). Protein synthesis rates were measured in vivo after administration of a flooding dose of L[1-13C]valine. 2. During the acute phase, muscle protein loss associated with infection resulted from both a decrease in protein synthesis and an increase in proteolysis. During the chronic phase and the late phase, the increase of proteolysis in infected rats as compared with pair-fed animals persisted, worsening muscle atrophy. Skin protein synthesis rates were not significantly modified by infection. However, skin protein content decreased 6 and 10 days after infection, suggesting an increased proteolysis in response to sepsis. 3. Protein synthesis in liver of infected rats was twice that of pair-fed animals. Liver protein synthesis remained elevated in infected rats compared with pair-fed animals until day 10. Hypoalbuminaemia and high plasma concentrations of fibrinogen were evident at all periods studied. alpha 2-Macroglobulin and alpha 1-acid glycoprotein reached peak concentrations during the acute phase (concentrations increased 50 times in infected rats). On day 10, the levels of these proteins were still about 12-fold higher. 4. Protein synthesis rates were significantly increased in the digestive tract and lung of infected rats compared with pair-fed groups on days 2 and 6, but were similar in the two groups on day 10 post-infection. The fractional protein synthesis rate was increased 3-fold over the entire experimental period in the spleen. 5. The results show that sepsis stimulates protein synthesis in various tissues over a long time, and that skin, like muscle, can provide amino acids to the rest of the body.


Assuntos
Músculo Esquelético/metabolismo , Proteínas/metabolismo , Sepse/metabolismo , Pele/metabolismo , Doença Aguda , Análise de Variância , Animais , Doença Crônica , Mucosa Intestinal/metabolismo , Fígado/metabolismo , Pulmão/metabolismo , Masculino , Proteínas Musculares/metabolismo , Biossíntese de Proteínas , Ratos , Ratos Sprague-Dawley , Baço/metabolismo
18.
J Nutr ; 128(1): 97-105, 1998 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-9430609

RESUMO

In vivo cysteine metabolism during the inflammatory state has been studied minimally. We investigated cysteine metabolism (i.e. taurine, sulfate and glutathione formation) using a single dose of [35S] cysteine in septic rats that had been injected with live Escherichia coli into the tail vein and in control, pair-fed rats. Cysteine metabolites were separated by ion exchange chromatography, and radioactivity was counted in the different fractions. Radioactivity incorporated in tissue proteins was also measured after protein precipitation. [35S]Sulfate production was significantly lower in septic rats than in pair-fed rats. [35S]Taurine contents were significantly lower only in kidneys, spleen and gastrointestinal tract of septic rats. The higher production of [35S] taurine in the livers (the major site of taurine production) of septic rats could have a protective effect against oxidation. Glutathione concentrations were also significantly greater in liver, spleen, kidneys and gastrocnemius muscle of septic rats, presumably in order to combat oxidative stress induced by sepsis. [35S]Cysteine incorporation in glutathione was significantly higher in spleen and kidneys but not in liver of septic rats compared to pair-fed rats. This could be explained by the fact that, in liver, a greater amount of labeled glutathione had been utilized for host defense, or by a high level in glutathione turnover. Finally, [35S]cysteine incorporation into protein, in septic rats, was significantly greater than in pair-fed rats in spleen, lung and particulary in whole plasma proteins other than albumin, which mainly represent the acute-phase proteins. These data suggest an increased requirement for cysteine during sepsis in rats.


Assuntos
Reação de Fase Aguda/metabolismo , Cisteína/metabolismo , Sepse/metabolismo , Animais , Peso Corporal , Infecções por Escherichia coli , Glutationa/análise , Glutationa/metabolismo , Masculino , Tamanho do Órgão , Especificidade de Órgãos , Proteínas/metabolismo , Ratos , Ratos Sprague-Dawley , Sepse/microbiologia , Sulfatos/análise , Sulfatos/metabolismo , Radioisótopos de Enxofre , Taurina/análise , Taurina/metabolismo
19.
Shock ; 7(6): 432-8, 1997 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9185244

RESUMO

Hyperlactatemia is a frequent complication of sepsis. We investigated the effect of pentoxifylline on plasma lactate concentrations and lactate release by epitrochlearis incubated in vitro following intravenous injection of Escherichia coli. Plasma lactate concentrations were elevated on day 2 postinfection and remained elevated for at least another 4 days. Lactate production by incubated epitrochlearis was not increased in septic rats on day 2 postinfection, and lactate production from muscles incubated with insulin (2 nM) or insulin-like growth factor-I, (10 nM) was similar in control and septic rats. On day 6 postinfection, lactate production was augmented 1.8-fold in muscles from septic rats and both insulin and IGF-I caused an exaggerated stimulation of lactate production compared with control. Pentoxifylline decreased plasma TNF concentrations 100-fold following injection of bacteria and prevented the sepsis-induced hyperlactatemia and increase in lactate production by incubated muscles in presence or absence of insulin or IGF-I. Thus, pentoxifylline prevented the sepsis-induced abnormalities in skeletal muscle lactate production and plasma lactate concentrations.


Assuntos
Bacteriemia/metabolismo , Escherichia coli , Fator de Crescimento Insulin-Like I/administração & dosagem , Insulina/administração & dosagem , Ácido Láctico/sangue , Músculo Esquelético/metabolismo , Pentoxifilina/administração & dosagem , Inibidores de Fosfodiesterase/administração & dosagem , Animais , Masculino , Músculo Esquelético/microbiologia , Ratos , Ratos Sprague-Dawley
20.
J Clin Invest ; 97(7): 1610-7, 1996 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-8601625

RESUMO

We studied the alterations in skeletal muscle protein breakdown in long lasting sepsis using a rat model that reproduces a sustained and reversible catabolic state, as observed in humans. Rats were injected intravenously with live Escherichia coli; control rats were pair-fed to the intake of infected rats. Rats were studied in an acute septic phase (day 2 postinfection), in a chronic septic phase (day 6), and in a late septic phase (day 10). The importance of the lysosomal, Ca2+ -dependent, and ubiquitin-proteasome proteolytic processes was investigated using proteolytic inhibitors in incubated epitrochlearis muscles and by measuring mRNA levels for critical components of these pathways. Protein breakdown was elevated during the acute and chronic septic phases (when significant muscle wasting occurred) and returned to control values in the late septic phase (when wasting was stopped). A nonlysosomal and Ca2+ -independent process accounted for the enhanced proteolysis, and only mRNA levels for ubiquitin and subunits of the 20 S proteasome, the proteolytic core of the 26 S proteasome that degrades ubiquitin conjugates, paralleled the increased and decreased rates of proteolysis throughout. However, increased mRNA levels for the 14-kD ubiquitin conjugating enzyme E2, involved in substrate ubiquitylation, and for cathepsin B and m-calpain were observed in chronic sepsis. These data clearly support a major role for the ubiquitin-proteasome dependent proteolytic process during sepsis but also suggest that the activation of lysosomal and Ca2+ -dependent proteolysis may be important in the chronic phase.


Assuntos
Proteínas Musculares/metabolismo , Músculo Esquelético/metabolismo , Atrofia Muscular/etiologia , Atrofia Muscular/metabolismo , Peptídeo Hidrolases/metabolismo , Sepse/complicações , Sepse/metabolismo , Animais , Cálcio/metabolismo , Cisteína Endopeptidases/genética , Cisteína Endopeptidases/metabolismo , Modelos Animais de Doenças , Ativação Enzimática , Infecções por Escherichia coli/genética , Infecções por Escherichia coli/metabolismo , Infecções por Escherichia coli/patologia , Humanos , Lisossomos/enzimologia , Masculino , Complexos Multienzimáticos/genética , Complexos Multienzimáticos/metabolismo , Músculo Esquelético/patologia , Atrofia Muscular/patologia , Tamanho do Órgão , Peptídeo Hidrolases/genética , Complexo de Endopeptidases do Proteassoma , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley , Sepse/patologia , Fatores de Tempo , Ubiquitinas/genética , Ubiquitinas/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...